Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion

PURPOSE: To assess treatment interval extension after switching from ranibizumab to aflibercept intravitreal injections in macular edema (ME) due to central retinal vein occlusion (CRVO) with an insufficient response or frequent recurrences to initial treatment. METHODS: CRVO eyes treated with ranib...

Descripción completa

Detalles Bibliográficos
Autores principales: Nghiem-Buffet, Sylvia, Glacet-Bernard, Agnès, Addou-Regnard, Manar, Souied, Eric H., Cohen, Salomon Y., Giocanti-Auregan, Audrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079418/
https://www.ncbi.nlm.nih.gov/pubmed/30116635
http://dx.doi.org/10.1155/2018/8656495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079418/
https://www.ncbi.nlm.nih.gov/pubmed/30116635
http://dx.doi.org/10.1155/2018/8656495

Ejemplares similares